Dapagliflozin has no effect on markers of bone formation and resorption or bone mineral density in patients with inadequately controlled type 2 diabetes mellitus on metformin - Ljunggren, Ö; Bolinder, J; Johansson, L (Diabetes Obes Metab, 2012)
et al.